<meta name="google-adsense-account" content="ca-pub-6363428395369086">

Aurobindo Pharma arm Acrotech Biopharma launches ADQUEY in US dermatology

Aurobindo Pharma’s Acrotech Biopharma has launched ADQUEY, a non-steroidal topical treatment for mild-to-moderate atopic dermatitis, in the US. The product enters a market estimated at around $1.3 billion for the 12 months ended July 2026, while Acrotech has established a dedicated dermatology business unit.

Source

Leave a Reply

Your email address will not be published. Required fields are marked *